Biotricity, Inc. (BTCY)

Biotricity, Inc. (BTCY) — VMCI valuation read

BTCY prints VMCI 41/100 inside the Healthcare sector, where the median sits at 50. The 9-point below-median delta is the cleanest single-number summary of Biotricity, Inc.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On BTCY, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** BTCY trades at 16.0x earnings, 11% below the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 3.2x is the binding constraint on the bear case; that is the risk line for Biotricity, Inc. on the trailing financials.

BTCY fell 2.4% over the trailing 7 days, with a +5.4% read on a 30-day basis.